Literature DB >> 2545781

Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus.

E Cash1, A Bandeira, S Chirinian, M Brahic.   

Abstract

Theiler's virus, a murine picornavirus, persists in the central nervous system of SJL/J mice and causes inflammation and demyelination in the white matter of spinal cord. We isolated inflammatory cells from the central nervous system of infected animals and studied their functions in vitro. Flow microfluorimetry analysis showed the presence of all major lymphocyte subsets, namely CD4+ and CD8+ T cells as well as B lymphocytes. B lymphocytes were activated in vitro and the antigenic specificity of secreted Ig was determined by immunoblotting. Secreted Ig reacted strongly with viral capsid proteins VP1 and VP2 and had neutralizing activity. They reacted also with two nonviral white matter components which were present only in infected animals. Therefore, it is likely that Igs secreted at the site of infection play a role in limiting virus spread. It is also possible that virus induced autoreactive antibodies participate in demyelination.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545781

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  Role of the humoral immune response in resistance to Theiler's virus infection.

Authors:  C P Rossi; E Cash; C Aubert; A Coutinho
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Role of macrophages during Theiler's virus infection.

Authors:  C P Rossi; M Delcroix; I Huitinga; A McAllister; N van Rooijen; E Claassen; M Brahic
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination.

Authors:  Kristen M Drescher; Laurie J Zoecklein; Moses Rodriguez
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

5.  Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Authors:  Francesca Gilli; Libin Li; Darlene B Royce; Krista D DiSano; Andrew R Pachner
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

6.  Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease.

Authors:  H Yahikozawa; A Inoue; C S Koh; Y K Choe; B S Kim
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  Lymphocyte recognition elements on the VP1 protein of Theiler's virus.

Authors:  E J Usherwood; I C Johnston; L J Lovelidge; P Tonks; A A Nash
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice.

Authors:  M K Njenga; K D Pavelko; J Baisch; X Lin; C David; J Leibowitz; M Rodriguez
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Theiler's virus infection of beta 2-microglobulin-deficient mice.

Authors:  L Fiette; C Aubert; M Brahic; C P Rossi
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus.

Authors:  A Inoue; Y K Choe; B S Kim
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.